Evidence map›Paper›PMID 37995333›Full record

Trial reportRevista medica del Instituto Mexicano del Seguro Social2023

[Functionality/isokinetic work of quadriceps in patients with gonarthrosis managed with prolotherapy].

Daniel Martínez-Barro, Joel Dair Rivera-Bello, Jannet Mercedes Cruz-López, Hermelinda Hernández-Amaro, David Rojano-Mejía

Abstract readRandomized Controlled TrialEnglish Abstract
In one paragraph

Trial report in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel Martínez-BarroInstituto Mexicano del Seguro Social, Unidad de Medicina Física y Rehabilitación Norte de la UMAE Traumatología, Ortopedia y Rehabilitación, "Dr. Victorio de la Fuente Narváez", Servicio de Rehabilitación. Ciudad de México, México.ORCID 0000-0002-7565-5349
Joel Dair Rivera-BelloHospital Ángeles Pedregal, Servicio de Neurofisiología Clínica. Ciudad de México, México.ORCID 0000-0002-2375-1929
Jannet Mercedes Cruz-LópezInstituto Mexicano del Seguro Social, Hospital General Regional No. 1 "Vicente Guerrero", Servicio de Rehabilitación. Acapulco, Guerrero, México.ORCID 0000-0002-3151-6961
Hermelinda Hernández-AmaroInstituto Mexicano del Seguro Social, UMAE Traumatología, Ortopedia y Rehabilitación, "Dr. Victorio de la Fuente Narváez", División de Educación en Salud. Ciudad de México, México.ORCID 0000-0003-0910-3535
David Rojano-MejíaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Coordinación de Investigación en Salud. Ciudad de México, México.ORCID 0000-0002-6340-8463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prolotherapy may be a good option in the complementary treatment of knee osteoarthritis (OA) patients, specifically for the increase of functionality. Objective: To determine the effectiveness of prolotherapy in OA grade II - III in the functionality and muscular work of knee flexors and extensors. Material and methods: a double-blind randomized controlled clinical trial was conducted. It included patients diagnosed with OA grades II-III. The experimental group was infiltrated in both knees with 6 ml of 25% glucose solution and 0.05% lidocaine; control group with 0.45% saline solution and 0.05% lidocaine. All patients received a comprehensive rehabilitation program. The isokinetic work of the knee flexor and extensor muscles, pain and functionality were measured, prior to infiltration and at 3-month follow-up. To compare the difference in means, the Student's T test was applied, considering P<0.05 as significant. The project was approved by the local ethics and research committee. Results: 37 patients were recruited, 17 in the prolotherapy group. There were no intergroup differences in functionality, isokinetic knee flexor/extensor work, and pain at baseline, or during follow-up up to 12 weeks. Conclusions: In the present study we identify that both prolotherapy and saline infiltration increased functionality, strength, and decreased pain; however, no statistically significant difference was found between the two group.

Indexed as

Osteoarthritis, KneeProlotherapyExercise TherapyHumansLidocainePainTreatment OutcomeLidocaineFuncionalidadFunctionalityMúsculo CuádricepsOsteoarthritis, KneeOsteoartritis de la RodillaProloterapiaProlotherapyQuadriceps Muscle

Identifiers

PMID37995333
PMCPMC10715815

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.